Association of cytochrome P450 induction with oxidative stress in vivo as evidenced by 3-hydroxylation of salicylate

Xenobiotica

Volumn 29, Issue 11, 1999, Pages 1171-1180

  Strolin Benedetti, M ^a,b   Brogin, G ^a,b   Bani, M ^a,b   Oesch, F ^c   Hengstler, J G ^c  

^a Zambon Group SpA   (Italy)

^b UCB PHARMA   (Belgium)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDROBENZOIC ACID; BENZOIC ACID DERIVATIVE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; DEXAMETHASONE; GENTISIC ACID; HYDROXYL RADICAL; PHENOBARBITAL; PROADIFEN; SALICYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG HYDROXYLATION; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; RAT;

ANIMALIA;

EID: 0032740986     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238038     Document Type: Article

References (22)

1. BANI, M., BROGIN, G., NAOI, M., MARUYAMA, W. and STROLIN BENEDETTI, M., 1997, Hydroxyl radical plasma concentrations in fed and fasting rats treated with streptozotocin. In Proceedings of the 6th European ISSX Meeting, Gothenburg, 30 June-3 July 3, abst., p. 74.
2. BAST, A., 1986, Is formation of reactive oxygen by cytochrome P-450 perilous and predictable? TIPS, 266-270.
3. BONDY, S. C. and NADERI, S., 1994, Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochemical Pharmacology, 48, 155-159.
4. CODERRE L., VALLEGA, G. A., PILCH, P. F. and CHIPKIN, S. R., 1996, In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. American Journal of Physiology, 34, E643-648.
5. COUNDRAY, C., TALLA, M., MARTIN, S., FATOME, M. and FAVIER, A., 1995, High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress. Annals of Biochemistry, 227, 101-111.
6. DUPONT, I., BERTHOU, F., BODENEZ, P., BARDOU, L., GUIRRIEC, C., STEPHAN, N., DREANO, Y. and LUCAS, D., 1999, Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans. Drug Metabolism and Disposition, 27, 322-326.
7. FALKNER, K. C., McCALLUM, G. P. and BEND, J. R., 1993, Effects of arsenite treatment on NAD(P)H: quinone acceptor oxidoreductase activity in liver, lung, kidney, and heart of the rat. Comparison to induction by the polyaromatic hydrocarbon beta-naphthoflavone. Drug Metabolism and Disposition, 21, 334-337.
8. FLOYD, R. A., 1983, Hydroxyl free-radical spin-adduct in rat brain synaptosomes. Observations on the reduction of the nitroxide. Biochimica et Biophysica Acta, 756, 204-216.
9. GROOTVELD, M. and HALLIWELL, B., 1986, Aromatic hydroxylation as a potential measure of hydroxyl- radical formation in vivo. Biochemical Journal, 237, 499-504.
10. INGELMAN-SUNDBERG, M., KAUR, H., TERELIUS, Y., PERSSON, J.-O. and HALLIWELL, B., 1991, Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Biochemical Journal, 276, 753-757.
11. JUNQUEIRA, V. B., SIMIZU, K., AZZALIS, L. A., BARROS, S. B., KOCH, O. and VIDELA, L. A., 1991, Effect of phenobarbital and 3-methylcholanthrene on the early oxidative stress component induced by lindane in rat liver. Xenobiotica, 21, 1053-1065.
12. LAWRENCE, G. D. and COHEN, G., 1985, In vivo production of ethylene from 2-keto-4-methylthiobutyrate in mice. Biochemical Pharmacology, 34, 3231-3236.
13. McMAHON, T. F., DILIBERTO, J. J. and BIRNBAUM, L. S., 1990, Effects of age and dose on disposition and metabolism of salicylic acid in male Fischer 344 rats. Drug Metabolism and Disposition, 18, 494-503.
14. PUNTARULO, S. and CEDERHAUM, A. I., 1992, Effect of phenobarbital and 3-methylcholanthrene treatment on NADPH- and NADH-dependent production of reactive oxygen intermediates by rat liver nuclei. Biochimica et Biophysica Acta, 1116, 17-23.
15. PUNTARULO, S. and CEDERBAUM, A. I., 1996, Role of cytochrome P-450 in the stimulation of microsomal production of reactive oxygen species by ferritin. Biochimica et Biophysica Acta, 1289, 238-246.
16. RICE-EVANS, C. A. and GOPINATHAN, V., 1995, Oxygen toxicity, free radicals and antioxidants in human disease: biochemical implications in atherosclerosis and the problems of premature neonates. Essays in Biochemistry, 29, 39-63.
17. SCHOLZ, W., SCHULTZE, K., KUNZ, W. and SCHWARZ, M., 1990, Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules. Cancer Research, 50, 7015-7022.
18. SINZ, M. W., WOOLF, T. F., 1997, Characterization of the induction of rat microsomal cytochrome P450 by tacrine. Biochemical Pharmacology, 54, 425-427.
19. VENKATESAN N., LIN, J., BOUCH, C., MARCIANO, D. and DAVIDSON, M. B., 1996, Dexamethasone- induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism, 45, 92-100.
20. YOSHIDA, T., YAMADA, Y., YAMAMOTO, T. and KUROIWA, Y., 1986, Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency. Xenobotica, 16, 129-136.
21. YOSHIDA, T., OGURO, T., and KUROIWA, Y., 1987, Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences. Xenobotica, 17, 957-963.
22. WORTELBOER, H.M., DEKRUIF, C. A., VANIERSEL, A. A. J., FALKE, H.E., NOORDHOEK, J. and BLAAUBOER, B. J., 1991, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochemical Pharmacology, 42, 381-390.